Pear-006 is a prescription digital therapeutic under investigation to treat depressive symptoms in patients with Multiple Sclerosis (MS).
It is expected to deliver access to cognitive behavioral therapy for people with MS under clinician supervision.
CAUTION: Pear-006 is an investigational therapeutic device. It is limited by United States law to investigational use. Pear-006 is not yet available for sale in the United States.